10-Q Filing

22ND CENTURY GROUP, INC. CIK: 1347858 Q3 2012

Filing Information

Form Type	10-Q
Accession Number	`0001144204-12-061634`
Period End Date	20120930
Filing Date	20121113
Fiscal Year	2012
Fiscal Period	Q3
XBRL Instance	xxii-20120930.xml

Filing Contents

This filing contains the following financial statements:

Balance Sheet 83 Income Statement 76 Cash Flow Statement 111 Stockholders Equity 16

Balance Sheet 83 line items

Line Item	Tag	Value	Unit	Period
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, shares authorized	`PreferredStockSharesAuthorized`	10.00M	shares	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, par value	`PreferredStockParOrStatedValuePerShare`	-	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash	`Cash`	$252.25K	USD	Point-in-time
Cash	`Cash`	$4.38K	USD	Point-in-time
Cash	`Cash`	$310.00	USD	Point-in-time
Preferred stock, shares issued	`PreferredStockSharesIssued`	-	shares	Point-in-time
Cash	`Cash`	$5.94K	USD	Point-in-time
Due from related Party	`DueFromRelatedPartiesCurrent`	$23.97K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Due from related Party	`DueFromRelatedPartiesCurrent`	$15.49K	USD	Point-in-time
Preferred stock, shares outstanding	`PreferredStockSharesOutstanding`	-	shares	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Due from officers	`DueFromOfficersOrStockholdersCurrent`	-	USD	Point-in-time
Due from officers	`DueFromOfficersOrStockholdersCurrent`	$7.71K	USD	Point-in-time
Common stock, shares authorized	`CommonStockSharesAuthorized`	300.00M	shares	Point-in-time
Inventory	`InventoryNet`	$1.15M	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Inventory	`InventoryNet`	$678.12K	USD	Point-in-time
Common stock, par value	`CommonStockParOrStatedValuePerShare`	-	USD	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$26.34K	USD	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	27.21M	shares	Point-in-time
Common stock, shares issued	`CommonStockSharesIssued`	31.05M	shares	Point-in-time
Prepaid expenses	`PrepaidExpenseCurrent`	$17.68K	USD	Point-in-time
Total current assets	`AssetsCurrent`	$1.21M	USD	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	31.05M	shares	Point-in-time
Common stock, shares outstanding	`CommonStockSharesOutstanding`	27.21M	shares	Point-in-time
Total current assets	`AssetsCurrent`	$971.25K	USD	Point-in-time
Patent and trademark costs, net	`IntangibleAssetsNetExcludingGoodwill`	$1.39M	USD	Point-in-time
Patent and trademark costs, net	`IntangibleAssetsNetExcludingGoodwill`	$1.37M	USD	Point-in-time
Office furniture and fixtures, net	`PropertyPlantAndEquipmentNet`	$7.86K	USD	Point-in-time
Office furniture and fixtures, net	`PropertyPlantAndEquipmentNet`	$6.49K	USD	Point-in-time
Deferred private placement costs	`DeferredCosts`	$46.88K	USD	Point-in-time
Deferred private placement costs	`DeferredCosts`	-	USD	Point-in-time
Deferred debt issuance costs, net	`DeferredFinanceCostsNoncurrentNet`	$8.46K	USD	Point-in-time
Deferred debt issuance costs, net	`DeferredFinanceCostsNoncurrentNet`	$22.41K	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$1.43M	USD	Point-in-time
Total other assets	`AssetsNoncurrent`	$1.42M	USD	Point-in-time
Total assets	`Assets`	$2.64M	USD	Point-in-time
Total assets	`Assets`	$2.39M	USD	Point-in-time
Demand bank loans	`ShortTermBankLoansAndNotesPayable`	$174.93K	USD	Point-in-time
Demand bank loans	`ShortTermBankLoansAndNotesPayable`	$174.93K	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.06M	USD	Point-in-time
Accounts payable	`AccountsPayableCurrent`	$1.31M	USD	Point-in-time
Accrued interest payable to related parties	`InterestPayableRelatedPartiesCurrent`	$3.72K	USD	Point-in-time
Accrued interest payable to related parties	`InterestPayableRelatedPartiesCurrent`	$21.50K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$554.41K	USD	Point-in-time
Accrued expenses	`AccruedLiabilitiesCurrent`	$545.58K	USD	Point-in-time
Due to officers	`DueToOfficersOrStockholdersCurrent`	-	USD	Point-in-time
Due to officers	`DueToOfficersOrStockholdersCurrent`	$50.21K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$425.00K	USD	Point-in-time
Notes payable	`NotesPayableCurrent`	$623.00K	USD	Point-in-time
Convertible notes, net of unamortized discount	`ConvertibleNotesPayableCurrent`	$1.55M	USD	Point-in-time
Convertible notes, net of unamortized discount	`ConvertibleNotesPayableCurrent`	$641.89K	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$4.27M	USD	Point-in-time
Total current liabilities	`LiabilitiesCurrent`	$2.87M	USD	Point-in-time
Long term portion of notes payable	`LongTermNotesPayable`	$177.00K	USD	Point-in-time
Long term portion of notes payable	`LongTermNotesPayable`	-	USD	Point-in-time
Convertible notes, net of unamortized discount	`ConvertibleLongTermNotesPayable`	-	USD	Point-in-time
Convertible notes, net of unamortized discount	`ConvertibleLongTermNotesPayable`	$77.72K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$550.00K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$653.93K	USD	Point-in-time
Warrant liability	`DerivativeLiabilitiesNoncurrent`	$3.06M	USD	Point-in-time
Total liabilities	`Liabilities`	$3.60M	USD	Point-in-time
Total liabilities	`Liabilities`	$5.00M	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Commitments and contingencies (Note 10)	`CommitmentsAndContingencies`	-	USD	Point-in-time
Preferred shares 10,000,000 authorized: $.00001 par value: 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Preferred shares 10,000,000 authorized: $.00001 par value: 0 shares issued and outstanding	`PreferredStockValue`	-	USD	Point-in-time
Common shares 300,000,000 authorized: .00001 par value: 31,048,979 (27,209,646 at December 31, 2011) issued and outstanding, respectively	`CommonStockValue`	$273.00	USD	Point-in-time
Common shares 300,000,000 authorized: .00001 par value: 31,048,979 (27,209,646 at December 31, 2011) issued and outstanding, respectively	`CommonStockValue`	$312.00	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapital`	$5.82M	USD	Point-in-time
Capital in excess of par value	`AdditionalPaidInCapital`	$7.11M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-9.47M	USD	Point-in-time
Accumulated deficit	`RetainedEarningsAccumulatedDeficit`	$-7.04M	USD	Point-in-time
Non-controlling interest - consolidated subsidiary	`MinorityInterest`	$5.98K	USD	Point-in-time
Non-controlling interest - consolidated subsidiary	`MinorityInterest`	-	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.21M	USD	Point-in-time
Total shareholders' deficit	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.36M	USD	Point-in-time
Total liabilities and shareholders' deficit	`LiabilitiesAndStockholdersEquity`	$2.39M	USD	Point-in-time
Total liabilities and shareholders' deficit	`LiabilitiesAndStockholdersEquity`	$2.64M	USD	Point-in-time

Income Statement 76 line items

Line Item	Tag	Value	Unit	Period
Revenue	`SalesRevenueNet`	$801.64K	USD	3 Qtrs
Revenue	`SalesRevenueNet`	$529.37K	USD	1 Quarter
Revenue	`SalesRevenueNet`	$15.68K	USD	3 Qtrs
Revenue	`SalesRevenueNet`	$15.68K	USD	1 Quarter
Other income - therapeutic grant	`RevenueFromGrants`	$223.54K	USD	3 Qtrs
Other income - therapeutic grant	`RevenueFromGrants`	-	USD	1 Quarter
Other income - therapeutic grant	`RevenueFromGrants`	-	USD	3 Qtrs
Other income - therapeutic grant	`RevenueFromGrants`	$80.00K	USD	1 Quarter
Total revenue	`Revenues`	$1.03M	USD	3 Qtrs
Total revenue	`Revenues`	$15.68K	USD	1 Quarter
Total revenue	`Revenues`	$609.37K	USD	1 Quarter
Total revenue	`Revenues`	$15.68K	USD	3 Qtrs
Costs of goods sold	`CostOfGoodsSold`	$130.50K	USD	1 Quarter
Costs of goods sold	`CostOfGoodsSold`	$224.15K	USD	3 Qtrs
Costs of goods sold	`CostOfGoodsSold`	$60.85K	USD	3 Qtrs
Costs of goods sold	`CostOfGoodsSold`	$60.85K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$1.51M	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$484.32K	USD	3 Qtrs
Research and development	`ResearchAndDevelopmentExpense`	$712.00K	USD	1 Quarter
Research and development	`ResearchAndDevelopmentExpense`	$155.32K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$370.24K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$451.09K	USD	1 Quarter
General and administrative	`GeneralAndAdministrativeExpense`	$1.38M	USD	3 Qtrs
General and administrative	`GeneralAndAdministrativeExpense`	$1.73M	USD	3 Qtrs
Sales and marketing costs	`SellingAndMarketingExpense`	$37.11K	USD	1 Quarter
Sales and marketing costs	`SellingAndMarketingExpense`	$11.36K	USD	1 Quarter
Sales and marketing costs	`SellingAndMarketingExpense`	$267.81K	USD	3 Qtrs
Sales and marketing costs	`SellingAndMarketingExpense`	$46.05K	USD	3 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$44.63K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$132.43K	USD	3 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$50.46K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$146.37K	USD	3 Qtrs
Costs and Expenses, Total	`CostsAndExpenses`	$648.23K	USD	1 Quarter
Costs and Expenses, Total	`CostsAndExpenses`	$1.38M	USD	1 Quarter
Costs and Expenses, Total	`CostsAndExpenses`	$3.51M	USD	3 Qtrs
Costs and Expenses, Total	`CostsAndExpenses`	$2.47M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-765.94K	USD	1 Quarter
Operating loss	`OperatingIncomeLoss`	$-2.45M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-2.49M	USD	3 Qtrs
Operating loss	`OperatingIncomeLoss`	$-632.55K	USD	1 Quarter
Warrant liability - net	`DerivativeGainsLossesNet`	$337.50K	USD	3 Qtrs
Warrant liability - net	`DerivativeGainsLossesNet`	$1.17M	USD	3 Qtrs
Warrant liability - net	`DerivativeGainsLossesNet`	$535.02K	USD	1 Quarter
Warrant liability - net	`DerivativeGainsLossesNet`	$337.50K	USD	1 Quarter
Related parties	`InterestExpenseRelatedParty`	$9.40K	USD	1 Quarter
Related parties	`InterestExpenseRelatedParty`	$194.07K	USD	3 Qtrs
Related parties	`InterestExpenseRelatedParty`	$28.18K	USD	3 Qtrs
Related parties	`InterestExpenseRelatedParty`	$55.79K	USD	1 Quarter
Other	`InterestExpenseOther`	$24.94K	USD	3 Qtrs
Other	`InterestExpenseOther`	$950.65K	USD	3 Qtrs
Other	`InterestExpenseOther`	$295.60K	USD	1 Quarter
Other	`InterestExpenseOther`	$12.53K	USD	1 Quarter
Nonoperating Income (Expense), Total	`NonoperatingIncomeExpense`	$284.38K	USD	3 Qtrs
Nonoperating Income (Expense), Total	`NonoperatingIncomeExpense`	$315.57K	USD	1 Quarter
Nonoperating Income (Expense), Total	`NonoperatingIncomeExpense`	$22.70K	USD	3 Qtrs
Nonoperating Income (Expense), Total	`NonoperatingIncomeExpense`	$183.62K	USD	1 Quarter
Net loss	`ProfitLoss`	$-2.43M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-2.21M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-450.37K	USD	1 Quarter
Net loss	`ProfitLoss`	$-448.93K	USD	1 Quarter
Net loss (income) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$-1.46K	USD	3 Qtrs
Net loss (income) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	-	USD	1 Quarter
Net loss (income) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$13.00K	USD	3 Qtrs
Net loss (income) attributable to non-controlling interest	`NetIncomeLossAttributableToNoncontrollingInterest`	$14.71K	USD	1 Quarter
Net loss attributed to common shareholders	`NetIncomeLoss`	$-2.43M	USD	3 Qtrs
Net loss attributed to common shareholders	`NetIncomeLoss`	$-448.93K	USD	1 Quarter
Net loss attributed to common shareholders	`NetIncomeLoss`	$-465.08K	USD	1 Quarter
Net loss attributed to common shareholders	`NetIncomeLoss`	$-2.22M	USD	3 Qtrs
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	3 Qtrs
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.08	USD	3 Qtrs
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.02	USD	1 Quarter
Loss per common share - basic and diluted	`EarningsPerShareBasicAndDiluted`	$-0.01	USD	1 Quarter
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	26.26M	shares	3 Qtrs
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	31.05M	shares	1 Quarter
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	27.21M	shares	1 Quarter
Common shares used in basic earnings per share calculation	`WeightedAverageNumberOfSharesOutstandingBasic`	29.48M	shares	3 Qtrs

Cash Flow Statement 111 line items

Line Item	Tag	Value	Unit	Period
Net loss	`ProfitLoss`	$-2.43M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-2.21M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-450.37K	USD	1 Quarter
Net loss	`ProfitLoss`	$-448.93K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$44.63K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$132.43K	USD	3 Qtrs
Amortization and depreciation	`DepreciationAndAmortization`	$50.46K	USD	1 Quarter
Amortization and depreciation	`DepreciationAndAmortization`	$146.37K	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	-	USD	3 Qtrs
Amortization of debt issuance costs	`AmortizationOfFinancingCosts`	$18.95K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$4.00K	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$1.05M	USD	3 Qtrs
Amortization of debt discount	`AmortizationOfDebtDiscountPremium`	$308.01K	USD	1 Quarter
Interest due to debt conversion	`NonCashInterestOnConvertibleDebt`	-	USD	3 Qtrs
Interest due to debt conversion	`NonCashInterestOnConvertibleDebt`	$31.35K	USD	3 Qtrs
Gain warrant liability - derivative	`DerivativeGainsLossesNet`	$337.50K	USD	3 Qtrs
Gain warrant liability - derivative	`DerivativeGainsLossesNet`	$1.17M	USD	3 Qtrs
Gain warrant liability - derivative	`DerivativeGainsLossesNet`	$535.02K	USD	1 Quarter
Gain warrant liability - derivative	`DerivativeGainsLossesNet`	$337.50K	USD	1 Quarter
Equity based employee compensation expense	`ShareBasedCompensation`	$776.44K	USD	3 Qtrs
Equity based employee compensation expense	`ShareBasedCompensation`	$327.46K	USD	3 Qtrs
Equity based payments for outside services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	-	USD	3 Qtrs
Equity based payments for outside services	`IssuanceOfStockAndWarrantsForServicesOrClaims`	$116.94K	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	-	USD	3 Qtrs
Accounts receivable	`IncreaseDecreaseInAccountsReceivable`	$86.68K	USD	3 Qtrs
Grant receivable	`IncreaseDecreaseInOtherReceivables`	-	USD	3 Qtrs
Grant receivable	`IncreaseDecreaseInOtherReceivables`	$-223.54K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$476.07K	USD	3 Qtrs
Inventory	`IncreaseDecreaseInInventories`	$524.73K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-162.58K	USD	3 Qtrs
Prepaid expenses	`IncreaseDecreaseInPrepaidExpense`	$-129.29K	USD	3 Qtrs
Deposits	`IncreaseDecreaseInDepositOtherAssets`	$-1.53K	USD	3 Qtrs
Deposits	`IncreaseDecreaseInDepositOtherAssets`	-	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$-65.81K	USD	3 Qtrs
Accounts payable	`IncreaseDecreaseInAccountsPayable`	$473.92K	USD	3 Qtrs
Accrued interest payable to related parties	`IncreaseDecreaseInDueToRelatedParties`	$-17.78K	USD	3 Qtrs
Accrued interest payable to related parties	`IncreaseDecreaseInDueToRelatedParties`	$-163.10K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$8.84K	USD	3 Qtrs
Accrued expenses	`IncreaseDecreaseInAccruedLiabilities`	$314.72K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	$-223.54K	USD	3 Qtrs
Deferred revenue	`IncreaseDecreaseInDeferredRevenue`	-	USD	3 Qtrs
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-1.30M	USD	3 Qtrs
Net cash used by operating activities	`NetCashProvidedByUsedInOperatingActivities`	$-2.47M	USD	3 Qtrs
Acquisition of patents and trademarks	`PaymentsToAcquireIntangibleAssets`	-	USD	3 Qtrs
Acquisition of patents and trademarks	`PaymentsToAcquireIntangibleAssets`	$570.64K	USD	3 Qtrs
Acquisition of office furniture and fixtures	`PaymentsToAcquireFurnitureAndFixtures`	-	USD	3 Qtrs
Acquisition of office furniture and fixtures	`PaymentsToAcquireFurnitureAndFixtures`	$9.11K	USD	3 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	-	USD	3 Qtrs
Net cash used by investing activities	`NetCashProvidedByUsedInInvestingActivities`	$-579.75K	USD	3 Qtrs
Proceeds from issuance of notes	`ProceedsFromNotesPayable`	$56.00K	USD	3 Qtrs
Proceeds from issuance of notes	`ProceedsFromNotesPayable`	$215.00K	USD	3 Qtrs
Payments on borrowings - notes payable	`RepaymentsOfNotesPayable`	$35.00K	USD	3 Qtrs
Payments on borrowings - notes payable	`RepaymentsOfNotesPayable`	$458.27K	USD	3 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	$210.00K	USD	3 Qtrs
Proceeds from issuance of convertible notes	`ProceedsFromConvertibleDebt`	-	USD	3 Qtrs
Deferred private placement costs	`DeferredFinancingAndOtherDebtRelatedCosts`	$10.00K	USD	3 Qtrs
Deferred private placement costs	`DeferredFinancingAndOtherDebtRelatedCosts`	-	USD	3 Qtrs
Net payments from related party	`PaymentFromRelatedParties`	$21.27K	USD	3 Qtrs
Net payments from related party	`PaymentFromRelatedParties`	$8.48K	USD	3 Qtrs
Net advances from officers	`ProceedsFromPaymentsForOtherFinancingActivities`	$28.22K	USD	3 Qtrs
Net advances from officers	`ProceedsFromPaymentsForOtherFinancingActivities`	$57.92K	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$1.06M	USD	3 Qtrs
Net cash provided by financing activities	`NetCashProvidedByUsedInFinancingActivities`	$3.06M	USD	3 Qtrs
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$-246.31K	USD	3 Qtrs
Net (decrease) increase in cash	`CashAndCashEquivalentsPeriodIncreaseDecrease`	$4.07K	USD	3 Qtrs
Cash - beginning of period	`Cash`	$252.25K	USD	Point-in-time
Cash - beginning of period	`Cash`	$4.38K	USD	Point-in-time
Cash - beginning of period	`Cash`	$310.00	USD	Point-in-time
Cash - beginning of period	`Cash`	$5.94K	USD	Point-in-time
Cash - end of period	`Cash`	$252.25K	USD	Point-in-time
Cash - end of period	`Cash`	$4.38K	USD	Point-in-time
Cash - end of period	`Cash`	$310.00	USD	Point-in-time
Cash - end of period	`Cash`	$5.94K	USD	Point-in-time
Cash paid during the period for interest	`InterestPaidNet`	$13.53K	USD	3 Qtrs
Cash paid during the period for interest	`InterestPaidNet`	$191.52K	USD	3 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Cash paid during the period for income taxes	`IncomeTaxesPaid`	-	USD	3 Qtrs
Common stock issued as payment of accounts payable	`IssuanceOfCommonStockInExchangeForAccountPayable`	$-359.75K	USD	3 Qtrs
Common stock issued as payment of accounts payable	`IssuanceOfCommonStockInExchangeForAccountPayable`	-	USD	3 Qtrs
Common stock issued as payment of deferred private placement costs	`IssuanceOfCommonStockValueInPaymentOfFinancingCost`	-	USD	3 Qtrs
Common stock issued as payment of deferred private placement costs	`IssuanceOfCommonStockValueInPaymentOfFinancingCost`	$36.88K	USD	3 Qtrs
Payment of accounts payable for deferred private placement costs	`PaymentOfAccountsPayableForDeferredPrivatePlacementCosts`	-	USD	3 Qtrs
Payment of accounts payable for deferred private placement costs	`PaymentOfAccountsPayableForDeferredPrivatePlacementCosts`	$500.00K	USD	3 Qtrs
Payment of accounts payable for patent costs	`PaymentOfAccountsPayableForPatentCosts`	-	USD	3 Qtrs
Payment of accounts payable for patent costs	`PaymentOfAccountsPayableForPatentCosts`	$526.13K	USD	3 Qtrs
Accounts payable converted to promissory notes	`ConversionOfAccountsPayableToNotePayable`	-	USD	3 Qtrs
Accounts payable converted to promissory notes	`ConversionOfAccountsPayableToNotePayable`	$587.00K	USD	3 Qtrs
Supplemental Accounts Payable, Total	`SupplementalAccountsPayable`	$396.63K	USD	3 Qtrs
Supplemental Accounts Payable, Total	`SupplementalAccountsPayable`	$1.61M	USD	3 Qtrs
Common stock issued for prepaid services	`CommonStockToBeIssuedForServices`	-	USD	3 Qtrs
Common stock issued for prepaid services	`CommonStockToBeIssuedForServices`	$171.25K	USD	3 Qtrs
Non controlling interest acquired for common stock	`AcquiredNoncontrollingInterest`	-	USD	3 Qtrs
Non controlling interest acquired for common stock	`AcquiredNoncontrollingInterest`	$4.53K	USD	3 Qtrs
Deferred private placement costs charged to contributed capital	`DeferredPrivatePlacementCostsChargedToContributedCapital`	$587.13K	USD	3 Qtrs
Deferred private placement costs charged to contributed capital	`DeferredPrivatePlacementCostsChargedToContributedCapital`	-	USD	3 Qtrs
Notes payable converted to common shares	`ConversionOfConvertibleNotesToCommonStock`	$120.75K	USD	3 Qtrs
Notes payable converted to common shares	`ConversionOfConvertibleNotesToCommonStock`	-	USD	3 Qtrs
Conversion of shareholder note and accrued interest to common shares and warrants	`ConversionOfNotesPayableToCommonStockBadExtended`	$614.07K	USD	3 Qtrs
Conversion of shareholder note and accrued interest to common shares and warrants	`ConversionOfNotesPayableToCommonStockBadExtended`	-	USD	3 Qtrs
Original issue discount on convertible debt	`IncreaseDecreaseInOriginalIssueDisountOnConvertibleDebt`	$12.60K	USD	3 Qtrs
Original issue discount on convertible debt	`IncreaseDecreaseInOriginalIssueDisountOnConvertibleDebt`	-	USD	3 Qtrs
Beneficial conversion value upon issuance of convertible debt recorded as debt discount and an increase in capital in excess of par value	`IncreaseDecreaseInBeneficialConversionFeature`	-	USD	3 Qtrs
Beneficial conversion value upon issuance of convertible debt recorded as debt discount and an increase in capital in excess of par value	`IncreaseDecreaseInBeneficialConversionFeature`	$63.60K	USD	3 Qtrs
Issuance of warrants as derivative liability instruments upon conversion of note payable	`SupplementalIssuanceOfWarrantLiability`	$152.10K	USD	3 Qtrs
Issuance of warrants as derivative liability instruments upon conversion of note payable	`SupplementalIssuanceOfWarrantLiability`	-	USD	3 Qtrs
Issuance of warrants as derivative liability instruments	`IssuanceOfWarrantsAsDerivativeLiabilityInstrument`	$92.75K	USD	3 Qtrs
Issuance of warrants as derivative liability instruments	`IssuanceOfWarrantsAsDerivativeLiabilityInstrument`	$3.06M	USD	3 Qtrs
Patent and trademark additions included in accounts payable	`PatentAndTrademarkAdditionsIncludedInAccountsPayable`	$124.08K	USD	3 Qtrs
Patent and trademark additions included in accounts payable	`PatentAndTrademarkAdditionsIncludedInAccountsPayable`	-	USD	3 Qtrs
Deferred debt issuance osts included in accounts payable	`DeferredPrivatePlacementCostAdditionsIncludedInAccountsPayable`	$5.00K	USD	3 Qtrs
Deferred debt issuance osts included in accounts payable	`DeferredPrivatePlacementCostAdditionsIncludedInAccountsPayable`	-	USD	3 Qtrs

Stockholders Equity 16 line items

Line Item	Tag	Value	Unit	Period
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.21M	USD	Point-in-time
Beginning balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.36M	USD	Point-in-time
Stock based compensation under Equity Incentive Plan	`StockIssuedDuringPeriodValueShareBasedCompensation`	$690.98K	USD	3 Qtrs
Common stock issued as payment of services and accounts payable	`StockIssuedDuringPeriodOfStockAndWarrantsForServicesOrClaimsBadExtended`	$534.83K	USD	3 Qtrs
Common stock issued upon exercise of Convertible Notes	`StockIssuedDuringPeriodValueConversionOfConvertibleSecurities`	-	USD	3 Qtrs
Common stock issued in May 2012 private placement	`StockIssuedDuringPeriodValueNewIssues`	$-4.53K	USD	3 Qtrs
Common stock issued in May 2012 private placement, shares	`StockIssuedDuringPeriodSharesNewIssues`	1.71M	shares	3 Qtrs
Beneficial conversion feature of convertible debt	`DebtInstrumentConvertibleBeneficialConversionFeature`	$1.06M	USD	Point-in-time
Beneficial conversion feature of convertible debt	`DebtInstrumentConvertibleBeneficialConversionFeature`	$63.60K	USD	3 Qtrs
Beneficial conversion feature of convertible debt	`DebtInstrumentConvertibleBeneficialConversionFeature`	$63.60K	USD	Point-in-time
Net loss	`ProfitLoss`	$-2.43M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-2.21M	USD	3 Qtrs
Net loss	`ProfitLoss`	$-450.37K	USD	1 Quarter
Net loss	`ProfitLoss`	$-448.93K	USD	1 Quarter
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-1.21M	USD	Point-in-time
Ending balance	`StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest`	$-2.36M	USD	Point-in-time

Data is extracted from SEC EDGAR XBRL filings. Values shown are as reported in the filing.